Literature DB >> 1370882

Three different NCA species, CGM6/CD67, NCA-95, and NCA-90, are comprised in the major 90 to 100-kDa band of granulocyte NCA detectable upon SDS-polyacrylamide gel electrophoresis.

M Kuroki1, Y Matsuo, T Kinugasa, Y Matsuoka.   

Abstract

Human granulocytes express several species of nonspecific cross-reacting antigens (NCA), glycoproteins belonging to the carcinoembryonic antigen (CEA) family. Our previous studies have shown that at least two different NCA of 95 and 90 kDa are contained in the major NCA band of 90 to 100 kDa detectable upon gel electrophoresis of immunoprecipitates obtained from the cell surfaces of granulocytes with polyclonal anti-NCA. In the present study, the 90 to 100-kDa NCA band was found to include one more species of 100 kDa. This component was reactive with an anti-CD67 antibody as well as polyclonal anti-NCA and released from the cell surface with phosphatidylinositol-specific phospholipase C, indicating that the 100-kDa NCA species is CD67. Both antibodies revealed high binding activities with a recombinant protein of CGM6, which has been identified in a leukocyte cDNA library as an NCA gene and found to encode a glycosyl-phosphatidylinositol-anchored heterotypic cell adhesion molecule. Furthermore, the apparent molecular mass of the deglycosylated CD67 (38 kDa) corresponded with that of the CGM6 protein. These results suggest that CD67 is equivalent to the NCA species CGM6.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370882     DOI: 10.1016/0006-291x(92)91760-n

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Current status of the prognostic molecular biomarkers in breast cancer: A systematic review.

Authors:  Goro Kutomi; Toru Mizuguchi; Fukino Satomi; Hideki Maeda; Hiroaki Shima; Yasutoshi Kimura; Koichi Hirata
Journal:  Oncol Lett       Date:  2017-01-17       Impact factor: 2.967

2.  Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells.

Authors:  Joan S Lewis-Wambi; Heather E Cunliffe; Helen R Kim; Amanda L Willis; V Craig Jordan
Journal:  Eur J Cancer       Date:  2008-07-07       Impact factor: 9.162

3.  Protein 1a: a major wheat germ agglutinin binding protein on the surface of human granulocytes associated with the cytoskeleton.

Authors:  P Mehta; S Zingde; S Advani; H Desai; B Gothoskar
Journal:  Mol Cell Biochem       Date:  1995-03-23       Impact factor: 3.396

4.  Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.

Authors:  Rosalyn D Blumenthal; Evelyn Leon; Hans J Hansen; David M Goldenberg
Journal:  BMC Cancer       Date:  2007-01-03       Impact factor: 4.430

5.  CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas.

Authors:  Ok-Jun Lee; Seung-Myoung Son; Kwon Pyo Hong; Yong-Moon Lee; Min-Young Kim; Jae-Woon Choi; Sang-Jeon Lee; Young-Jin Song; Hak Soon Kim; Wun-Jae Kim; See-Ok Shin; Hyung Geun Song
Journal:  Virchows Arch       Date:  2014-11-27       Impact factor: 4.064

6.  Synthetic peptides from the N-domains of CEACAMs activate neutrophils.

Authors:  K M Skubitz; K D Campbell; A P Skubitz
Journal:  J Pept Res       Date:  2001-12

7.  T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction.

Authors:  Jessica Pinkert; Hans-Henning Boehm; Mark Trautwein; Wolf-Dietrich Doecke; Florian Wessel; Yingzi Ge; Eva Maria Gutierrez; Rafael Carretero; Christoph Freiberg; Uwe Gritzan; Merlin Luetke-Eversloh; Sven Golfier; Oliver Von Ahsen; Valentina Volpin; Antonio Sorrentino; Anchana Rathinasamy; Maria Xydia; Robert Lohmayer; Julian Sax; Ayse Nur-Menevse; Abir Hussein; Slava Stamova; Georg Beckmann; Julian Marius Glueck; Dorian Schoenfeld; Joerg Weiske; Dieter Zopf; Rienk Offringa; Bertolt Kreft; Philipp Beckhove; Joerg Willuda
Journal:  Oncoimmunology       Date:  2021-12-30       Impact factor: 8.110

8.  Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma.

Authors:  M Kobayashi; Y Miki; M Ebina; K Abe; K Mori; S Narumi; T Suzuki; I Sato; M Maemondo; C Endo; A Inoue; H Kumamoto; T Kondo; H Yamada-Okabe; T Nukiwa; H Sasano
Journal:  Br J Cancer       Date:  2012-10-25       Impact factor: 7.640

9.  Effective combination gene therapy using CEACAM6-shRNA and the fusion suicide gene yCDglyTK for pancreatic carcinoma in vitro.

Authors:  Hongyu Long; Qingfu Li; Yuan Wang; Qian Li; Ting Liu; Jie Peng
Journal:  Exp Ther Med       Date:  2012-10-30       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.